Liver disease as a risk factor for cognitive decline and dementia: An under-recognized issue

Hepatology

Volumn 49, Issue 2, 2009, Pages 698-

  Yilmaz, Yusuf ^a   Ozdogan, Osman ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; SOMATOMEDIN C;

ALZHEIMER DISEASE; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; BILIARY CIRRHOSIS; CAROTID ATHEROSCLEROSIS; CHRONIC LIVER DISEASE; COGNITIVE DEFECT; DEMENTIA; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS C; HUMAN; LETTER; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RISK FACTOR; WORKING MEMORY; FATTY LIVER; FEMALE; FOLLOW UP; MALE; NOTE; PSYCHOLOGICAL ASPECT; TIME;

COGNITION DISORDERS; DEMENTIA; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; TIME FACTORS;

EID: 61949269213     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22752     Document Type: Letter

References (9)

1. Newton JL, Hollingsworth KG, Taylor R, El-Sharkawy AM, Khan ZU, Pearce R, et al. Cognitive impairment in primary biliary cirrhosis: Symptom impact and potential etiology. HEPATOLOGY 2008;48:541-549.
2. Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. HEPATOLOGY 2002;35:433-439.
3. Karaivazoglou K, Assimakopoulos K, Thomopoulos K, Theocharis G, Messinis L, Sakellaropoulos G, et al. Neuropsychological function in Greek patients with chronic hepatitis C. Liver Int 2007;27:798-805.
4. Trejo JL, Piriz J, Llorens-Martin MV, Fernandez AM, Bolós M, Le Roith D, et al. Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects. Mol Psychiatry 2007; 12:1118-1128.
5. Brea A, Mosquera D, Martín E, Arizti A, Cordero JL, Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: A case-control study. Arterioscler Thromb Vasc Biol 2005;25:1045-1050.
6. Spence JD. Carotid intima-media thickness and cognitive decline: What does it mean for prevention of dementia? J Neurol Sci 2004;223:103-105.
7. Cortez-Pinto H, Camilo ME, Baptista A, De Oliveira AG, De Moura MC. Non-alcoholic fatty liver: Another feature of the metabolic syndrome? Clin Nutr 1999;18:353-358.
8. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004;292:2237-2242.
9. Yavuz BB, Yavuz B, Halil M, Cankurtaran M, Ulger Z, Cankurtaran ES, et al. Serum elevated gamma glutamyltransferase levels may be a marker for oxidative stress in Alzheimer's disease. Int Psychogeriatr 2008;20:815-823.